leadf
logo-loader
viewIXICO PLC

IXICO's Lammert Albers discusses expanded contract for imaging services with Vaccinex

IXICO PLC's (LON:IXI) chief business officer Lammert Albers talks Proactive's Andrew Scott through an extended contract they've secured with Vaccinex Inc (NASDAQ:VCNX).

It's to provide services on a trial of a potential treatment for Alzheimer’s disease.

The company’s digital platform and artificial intelligence (AI) software manages and helps interpret images from magnetic resonance imaging (MRI) and other scanners.

Quick facts: IXICO PLC

Price: 83.5 GBX

AIM:IXI
Market: AIM
Market Cap: £39.32 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

IXICO CEO 'delighted' with stronger than anticipated second half growth

IXICO PLC's (LON:IXI) Giulio Cerroni caught up with Proactive London's Katie Pilbeam after announcing they've raised earnings expectations for the current fiscal year. He says revenues for the year to the end of September 2020 will be in line with, or slightly ahead of, current market...

on 24/8/20

2 min read